Titan Pharmaceuticals Inc (NASDAQ:TTNP)

0.83
Delayed Data
As of May 25
 +0.048 / +6.14%
Today’s Change
0.60
Today|||52-Week Range
2.85
-37.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues3.6M1.7M15.1M215.0K
 
 
 
 
 
Depreciation And Amortization353.0K358.0K377.0K417.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.3M------
 
 
General Expenses6.8M8.1M10.3M14.3M
 
 
 
 
 
Research And Development4.1M4.7M6.1M9.6M
 
 
 
 
 
Total Operating Expenses7.1M8.4M10.7M14.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-6.8M4.3M-14.5M
 
 
 
 
 
Extraordinary Credit1.1M0.00825.0K619.0K
 
 
 
 
Extraordinary Charge0.00-4.5M0.000.00
 
 
Interest Expense On Debt--0.000.00369.0K
 
 
Other Expenses-11.0K-8.0K-70.0K-55.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.4M-11.3M5.1M-14.3M
 
 
 
 
 
Net Income-2.4M-11.3M5.1M-14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.1M20.1M20.7M21.2M
 
 
 
 
 
Shares To Calculate EPS Diluted17.1M20.1M21.5M21.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.56$0.20-$0.70
 
 
 
 
 
EPS Diluted-$0.22-$0.56$0.20-$0.70